1 Min Read
April 5 (Reuters) - AC Immune SA:
* AC IMMUNE ANNOUNCES SELECTION OF TAU SMALL MOLECULES FOR CLINICAL DEVELOPMENT IN ALZHEIMER’S DISEASE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.